EquityFlow › Companies › Avanzanite

Avanzanite

Biotech · Amsterdam, NL

Sviluppa e distribuisce farmaci per malattie rare in tutta Europa

Funding history

DateRoundAmount
Nov 2025Series A
Amsterdam-based Avanzanite closed a €32M Series A from MVM Partners to scale rare disease treatments in Europe.
$37.1M

Investors

MVM Partners

Similar companies in Biotech

ImperagenHaga BiosciencePixelgen TechnologiesGallantChai DiscoverySNIPR BiomeCellbox LabsScope BiosciencesGenLuminaActitheraNUCLIDIUMAnocca
Explore funding flow on EquityFlow →